Risk of Atherosclerosis in Women with Polycystic Ovary Syndrome: A Study from South India

Metabolic Syndrome and Related Disorders

Volumn 1, Issue 4, 2003, Pages 271-275

  Sundararaman, P G ^a   Manomani, R ^a   Sridhar, G R ^b   Sridhar, V ^c   Sundaravalli, A ^c   Umachander, Meena ^c  

^a Institute of Obstetrics and Gynecology   (India)

^b Endocrine and Diabetes Centre   (India)

^c Sono Diagnostics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010385584     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/1540419031361435     Document Type: Article

References (26)

1. Wild RA. Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol 2002; 186: 35–43.
2. Kelly CJG, Speirs A, Gould GW, et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 742–746.
3. Yajnik CS, Fall CH, Coyaji KJ, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord 2003; 27: 173–180.
4. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycstic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694–2698.
5. Zargar AH, Wani AI, Masoodi SR, et al. Epidemiological and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent. Fertil Steril 2002; 77:674–678.
6. Mithal A, Ammini AC, Godbole MM, et al. Lateonset adrenal hyperplasia in north Indian hirsute women. Horm Res 1988; 30: 1–4.
7. Rodin DA, Bano G, Bland JM, et al. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 1998; 49: 91–99.
8. Jialal I, Naiker P, Reddi K, et al. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987; 64: 1066–1069.
9. Kauffman RP, Castracane D. Assessing insulin sensitivity. Cont Ob/Gyn 2003; 1: 30–48.
10. Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000; 20: 2414–2421.
11. Dunaif A, Wu X, Lee A, et al. Defects insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 2001; 281: 392–399.
12. Hedblad B, Wikstrand J, Janzon I, et al. Low-dose metoprolol CR/XL and fluvastain slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001; 103: 721–726.
13. Smilde TJ, van Wissen S, Wollersheim H, et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357: 577–581.
14. Singh TP, Grroehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003; 41: 661–665.
15. Kurktschiev TST, Koehler C, Leonhardt W, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 1999; 22: 333–338.
16. Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000; 23: 401–406.
17. Snehalatha C, Vijay V, Suresh Mohan R, et al. Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects. Diabetes Metab Res Rev 2001; 17: 444–447.
18. Mohan V, Ravikumar R, Shanthi Rani S, et al. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 2000; 43:494–499.
19. Ravikumar R, Deepa R, Shanthirani CS, et al. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002; 90: 702–707.
20. Gonzalez F, Thusu K, Abdel-Rahman E, et al. Elevated serum levels of tumor necrosis factor-alpha in normal-weight women with polycystic ovary syndrome. Metabolism 1999; 48: 437–441.
21. Dandona P, Aljada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation and atherosclerosis. Am J Cardiol 2002; 90: 27G–33G.
22. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002; 45: 924–930.
23. King H, Aubert RE, Herman WH. Global burden of diabetes. 1995–2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414–1431.
24. Sridhar GR, Rao PV, Ahuja MMS. Epidemiology of diabetes and its complications. In: Ahuja MMS, et al, eds. RSSDI Textbook of Diabetes. Hyderabad: Research Society for the Study of Diabetes in India, 2002: 95–119.
25. Sridhar GR, Madhu K. Psychosocial and cultural issues in diabetes mellitus. Curr Sci 2002; 83: 1556–1564.
26. Normal RJ, Davies MJ, Lord J, et al. The role of life-style modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002; 13: 251–257.